Differentiation of amniotic epithelial cells into various liver cell types and potential therapeutic applications

Placenta. 2017 Nov:59:139-145. doi: 10.1016/j.placenta.2017.03.020. Epub 2017 Mar 30.

Abstract

The aim of Regenerative Medicine is to replace or regenerate human cells, tissues or organs in order to restore normal function. Among all organs, the liver is endowed with remarkable regenerative capacity. Nonetheless, there are conditions in which this ability is impaired, and the use of isolated cells, including stem cells, is being considered as a possible therapeutic tool for the management of chronic hepatic disease. Placenta holds great promise for the field of regenerative medicine. It has long been used for the treatment of skin lesions and in ophthalmology, due to its ability to modulate inflammation and promote healing. More recently, cells isolated from the amniotic membrane are being considered as a possible resource for tissue regeneration, including in the context liver disease. Two cell types can be easily isolated from human amnion: epithelial cells (hAEC) and mesenchymal stromal cells (hAMSC). However only the first cell population has been demonstrated to be a possible source of proficient hepatic cells. This review will summarize current knowledge on the differentiation of hAEC into liver cells and their potential therapeutic application.

Keywords: Amniotic epithelial cells; Cell therapy; Hepatocytes; Regenerative medicine; Stem cell differentiation.

Publication types

  • Review

MeSH terms

  • Amnion / cytology*
  • Animals
  • Cell Differentiation*
  • Cell Transplantation*
  • Epithelial Cells / physiology*
  • Humans
  • Liver / cytology
  • Liver Diseases / therapy*
  • Regenerative Medicine